Agentix Corp. (AGTX)
OTCMKTS · Delayed Price · Currency is USD
0.0200
-0.0011 (-5.21%)
At close: Jun 30, 2026
Agentix Market Cap
Agentix has a market cap or net worth of $801.34 thousand as of July 8, 2026. Its market cap has decreased by -97.28% in one year.
Market Cap
801.34K
Enterprise Value
1.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since June 10, 2020, Agentix's market cap has decreased from 11.57M to 801.34K, a decrease of -93.08%. That is a compound annual growth rate of -35.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 801.34K | -46.67% |
| Dec 31, 2025 | 1.50M | -78.87% |
| Dec 30, 2024 | 7.11M | 472.50% |
| Dec 14, 2023 | 1.24M | -81.27% |
| Dec 29, 2022 | 6.63M | -62.19% |
| Dec 29, 2021 | 17.54M | 1.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZyVersa Therapeutics | 1.25M |
| Evofem Biosciences | 1.19M |
| Avenue Therapeutics | 1.09M |
| Abpro Holdings | 1.07M |
| Emmaus Life Sciences | 801.62K |
| Windtree Therapeutics | 764.79K |
| Burzynski Research Institute | 719.02K |
| SQZ Biotechnologies Company | 707.79K |